Daftar Pustaka
Akyildiz EU, Oz B, Comunoglu N, Aki H. 2010. The relationship between
histomorphological characteristics and Ki-67 proliferation index in
meningiomas. Bratisl lek listy, 111(9):505-509.
Al-Hadidy AM, Maani WS, Mahafza WS, Al-Najar MS, Al-Nadii MM. 2007.
Intracranial Meningioma. J Med J, 41(1):37-51.
Al-Mefty O, Heth J. 2005. Meningiomas. In: Rengachary SS, Ellenbogen RG,
editors. Principles of neurosurgery. 2nd
Barnholtz-Sloan JS, Kruchko C. 2007. Meningiomas: causes and risk factors.
Neurosurg Focus, 23(4): E2.
ed. China: Elsevier Mosby.
p.487-500.
Bernauer S, Wehling M, Gerdes D, Falkenstein E. 2001. The human membrane
progesterone receptor gene: Genomic structure and promoter analysis.
Mitochondrial, 12(1):13-25.
Calvocoressi L, Claus EB. 2010. Epidemiology and Natural History of
Meningioma. In: Pamir MN, Black PM, Fahlbusch R, editors.
Meningiomas: A comprehensive text. New York: Saunders Elsevier.
p.61-77.
Camacho-Arroyo I, Rodriguez-Dorantes M. 2006. Transcriptional activity
regulated by progesterone receptor isoforms. Molecular endocrinology,
2:25-38.
Carroll RS, Brown M, Zhang J. 2000. Expression of a subset of steroid receptor
cofactors is associated with progesterone receptor expression in
meningiomas. Clin Cancer Res, 6:3570-3575.
Cea-Soriano L, Wallander MA, Garcia Rodiquez LA. 2012. Epidemiology of
meningioma in the United Kingdom. Neuroepidemiology, 39(1):27-34.
Chou SM, Miles JM. 1991. The pathology of meningiomas. In: Al-Mefty O,
editor. Meningiomas. New York: Raven press .p.37-57.
Choy W, Kim W, Nagasawa D, Stramotas S, Yew A, Gopen Q, et al. 2011. The
molecular genetics and tumor pathogenesis of meningiomas and the future
directions of meningioma treatments. Neurosurg Focus, 30(5):E6
Claus EB, Bondy ML, Schildkraut JM, Wiemels JL,Wrensch M, Black PM. 2005.
Epidemiology of Intracranial Meningioma. Neurosurgery, 57:1088-1095.
Claus EB, Calvocoressi L, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M.
2012. Dental x-rays and risk of meningioma. Cancer, 118(18):4530-4537.
Dowd CF, Halbach VV, Higashida RT. 2003. Meningiomas: the role of
perioperative angiography and embolization. Neurosurg Focus, 15(1):1-4.
Evans DGR, Watson C, King A, Wallace AJ, Baser ME. 2005. Multiple
meningiomas: differential involvement of the NF2 gene in children and
adults. J Med Genet, 42:45-48.
Fakhrjou A, Meshkini A, Shadrvan S. 2012. Status of Ki-67, estrogen and
progesterone receptors in various subtypes of intracranial meningiomas.
Pakistan Journal of Biological Sciences, 15(11):530-535.
Fischer BR, Brokinkel. 2012. Surgical management of skull base meningiomas –
An overview. In: Meningiomas – Management and surgery. Monleon D,
ed. Shanghai, China. InTech, 85-102.
Kim YJ, Ketter R, Steudel WI, Feiden W. 2007. Prognostic significance of the
mitotic index using the mitotic marker anti-phosphohistone H3 in
meningiomas. Am J Clin Pathol, 128:118-125.
Korhonen K. 2012. Pathological and epidemiological aspects of meningioma with
special emphasis to sex hormones [dissertation]. Tampere: University of
Tampere.
Lai R, Crevier L, Thabane L. 2005. Genetic polymorphisms of Glutathione
S-Transferases and the risk of adult brain tumors: A meta-analysis. Cancer
epidemiol biomarkers prev,14(7):1784-1790.
Levacic D, Nochlin D, Steineke T, Landolfi JC. 2012. Management of malignant
meningiomas. In: Meningiomas – Management and surgery. Monleon D.
InTech, Shanghai. P: 1-34.
Malmer B, Feychting M, Lonn S, Ahlbom A, Henriksson R. 2005. p53 genotypes
and risk of glioma and meningioma. Cancer epidemiol biomarkers prev,
14(9):2220-2223.
Mary AK, Abuya JM, Chumba D, Koech FK. 2013. Association of radiological
CTand MRI scan features to the histopathology of meningiomas in
patients at major hospital in Eldoret Town, Kenya. International journal of
advanced research, 1(4):104-114.
Minniti G, Amichetti M, Enrici RM. 2009. Radiotherapy and radiosurgery for
benign skull base meningiomas. Radiation oncolog, 4:42.
Modha A, Gutin PH. 2005. Diagnosis and treatment of atypical anaplastic
meningiomas: A review. Neurosurgery, 57:538-550.
Omulecka A, Papierz W, Nawrocka-Kunecka A, Lewy-Trenda I. 2006.
Immunohistochemical expression of progesterone and estrogen receptors
in meningiomas. Folia Neuropathol, 44(2):111-115.
Osborn AG, Blaser SI, Salzman KL, Katzman GL, Provenzale J, Castillo M, et al,
editors. 2004. Diagnostic Imaging brain. Utah: Amirsys Inc.
p.II.4.56-II.4.63
Phillips LE, Koepsell TD, Van Belle G, Kukull WA, Gehrels JA, Longstreth WT
Jr. 2002. History of head trauma and risk of intracranial meningioma:
population-based case-control study. Neurology, 58(12):1849-1852.
Rockhill M, Rugala M, Chamberlain MC. 2007. Intracranial Meningiomas: an
overview of diagnosis and treatment. Neurosurg Focus, 23(4):1-7.
Roser F, Nakamura M, Bellinzona, Rosahl SK, Ostertag H, Samii M. 2004. The
prognostic value of progesterone receptor status in meningiomas. J Clin
Pathol, 57:1033-1037.
Scarpin KM, Graham JD, Mote PA, Clarke CL. 2009. Progesterone action in
human tissues: Regulation by progesterone receptor (PR) isoform
expression, nuclear positioning and coregulator expression. Nuclear
receptor signaling, 9:1-13
Shayanfar N, Mashayekh M, Mohammadpour M. 2010. Expression of
progesterone receptor and proliferative marker ki 67 in various grades of
meningioma. Acta Medica Iranica, 48(3):142-147
Smith MJ, Higgs JE, Bowers NL, Halliday D, Paterson J, Gillespie J, et al. 2011.
Cranial meningiomas in 411 NF2 patients with proven gene mutations:
Clear positional effect of mutations, but absence of female severity effect
on age at onset. Journal of Medical Genetics, 48:1-22.
Taghipour M, Rakei SM, Monabati A, Nahavandi-Nejad M. 2007. The role of
estrogen and progesterone receptors in grading of the malignancy of
menigioma. IRCMJ, 9(1):17-21
Talacchi A, Corsini F, Gerosa M. 2011. Hyperostosing meningiomas of the
cranial vault with and without tumor mass. Acta neurochir, 153:53-61
Wiemels J, Wrensch M, Claus EB. 2010. Epidemiology and etiology of
meningioma. JNeurooncol, 99(3):307-314.
